CELG-RI Financials
Bristol Myers Squibb Co - Financial statements & key metrics
Stock Price
$0.09
Market Cap
-
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$48.30B
Gross Profit
-
Operating Income
-
Net Income
$-8.93B
EPS (Diluted)
$-4.41
Balance Sheet Highlights
Total Assets
$92.60B
Total Liabilities
$76.22B
Shareholders Equity
-
Cash & Equivalents
$10.35B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$15.19B
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CELG-RI revenue?
CELG-RI's most recent quarterly revenue was $48.30B. Annual revenue can be calculated by summing the four most recent quarters.
Is CELG-RI profitable?
CELG-RI reported a loss of $8.93B in the most recent quarter.
What is CELG-RI market cap?
Market cap data for CELG-RI is available above.
Does CELG-RI have debt?
View CELG-RI's balance sheet for debt information.
What is CELG-RI cash flow?
Cash flow data is available in the full financial statements.